GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Teva Pharmaceutical Industries Ltd (FRA:TEV) » Definitions » Cyclically Adjusted PS Ratio

Teva Pharmaceutical Industries (FRA:TEV) Cyclically Adjusted PS Ratio : 0.78 (As of May. 22, 2025)


View and export this data going back to . Start your Free Trial

What is Teva Pharmaceutical Industries Cyclically Adjusted PS Ratio?

As of today (2025-05-22), Teva Pharmaceutical Industries's current share price is €14.50. Teva Pharmaceutical Industries's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was €18.59. Teva Pharmaceutical Industries's Cyclically Adjusted PS Ratio for today is 0.78.

The historical rank and industry rank for Teva Pharmaceutical Industries's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:TEV' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.27   Med: 0.65   Max: 4.09
Current: 0.81

During the past years, Teva Pharmaceutical Industries's highest Cyclically Adjusted PS Ratio was 4.09. The lowest was 0.27. And the median was 0.65.

FRA:TEV's Cyclically Adjusted PS Ratio is ranked better than
75.58% of 737 companies
in the Drug Manufacturers industry
Industry Median: 2.05 vs FRA:TEV: 0.81

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Teva Pharmaceutical Industries's adjusted revenue per share data for the three months ended in Mar. 2025 was €3.105. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €18.59 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Teva Pharmaceutical Industries Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Teva Pharmaceutical Industries's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Teva Pharmaceutical Industries Cyclically Adjusted PS Ratio Chart

Teva Pharmaceutical Industries Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.38 0.33 0.40 0.49 1.09

Teva Pharmaceutical Industries Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.66 0.79 0.87 1.09 0.76

Competitive Comparison of Teva Pharmaceutical Industries's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teva Pharmaceutical Industries's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Teva Pharmaceutical Industries's Cyclically Adjusted PS Ratio falls into.


;
;

Teva Pharmaceutical Industries Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Teva Pharmaceutical Industries's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=14.50/18.59
=0.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teva Pharmaceutical Industries's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Teva Pharmaceutical Industries's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=3.105/134.9266*134.9266
=3.105

Current CPI (Mar. 2025) = 134.9266.

Teva Pharmaceutical Industries Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 5.151 100.684 6.903
201509 4.985 100.392 6.700
201512 5.115 99.792 6.916
201603 4.695 100.470 6.305
201606 4.874 101.688 6.467
201609 5.037 101.861 6.672
201612 6.046 101.863 8.008
201703 5.194 102.862 6.813
201706 5.006 103.349 6.536
201709 4.634 104.136 6.004
201712 4.047 104.011 5.250
201803 4.027 105.290 5.161
201806 3.953 106.317 5.017
201809 3.813 106.507 4.830
201812 3.393 105.998 4.319
201903 3.367 107.251 4.236
201906 3.384 108.070 4.225
201909 3.403 108.329 4.239
201912 3.685 108.420 4.586
202003 3.598 108.902 4.458
202006 3.124 108.767 3.875
202009 3.081 109.815 3.786
202012 3.342 109.897 4.103
202103 3.022 111.754 3.649
202106 2.926 114.631 3.444
202109 2.978 115.734 3.472
202112 3.293 117.630 3.777
202203 3.003 121.301 3.340
202206 3.226 125.017 3.482
202209 3.245 125.227 3.496
202212 3.293 125.222 3.548
202303 3.068 127.348 3.251
202306 3.195 128.729 3.349
202309 3.178 129.860 3.302
202312 3.652 129.419 3.807
202403 3.129 131.776 3.204
202406 3.414 132.554 3.475
202409 3.444 133.029 3.493
202412 3.561 133.157 3.608
202503 3.105 134.927 3.105

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Teva Pharmaceutical Industries  (FRA:TEV) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Teva Pharmaceutical Industries Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Teva Pharmaceutical Industries Business Description

Address
124 Dvora HaNevi’a Street, Tel Aviv, ISR, 6944020
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

Teva Pharmaceutical Industries Headlines

No Headlines